Francisco Chacón-Lozsán/LinkedIn
Mar 22, 2026, 14:46
Francisco Chacón-Lozsán: PE Is The New STEMI, But Are We Treating It Too Aggressively?
Francisco Chacón-Lozsán, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine (ESICM) and American College of Cardiology, shared on LinkedIn:
”’PE is the new STEMI’ — but are we treating it too aggressively?
One of the most thought-provoking sessions at ACVC26 challenged the growing enthusiasm for catheter-directed therapies.
The message was clear:
- Not every PE needs intervention
- In fact, most patients do well with anticoagulation alone
- The real challenge is not how to treat – but who to treat.
Current risk scores don’t capture the full picture
More evidence is underway.
We need to move toward:
- Better understanding of RV failure
- Early identification of decompensation
- Truly individualized decision-making
Until then: Avoid ‘wild’ use of catheter-based therapies”
Stay updated with Hemostasis Today.
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge